Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VELCADE Maintenance in Multiple Myeloma Post-SCT
NCT00311337Phase 2Unknown
- Start
- Oct 2005
- Modality
- Small Molecules, Modified Peptides
- Countries
- 3
01
Overview
A Phase 2 trial of bortezomib in multiple myeloma (MM). Status: unknown.
02
Drugs
bortezomib
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00311337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00311337.